. RNA polymerase (Pol) III is the essential, evolutionarily conserved enzyme that generates short, non-coding RNAs, including tRNAs and 5S rRNA 2 . The historical focus on transcription of protein-coding genes has left the roles of Pol III in organismal physiology relatively unexplored. Target of rapamycin kinase complex 1 (TORC1) regulates Pol III activity, and is also an important determinant of longevity 3 . This raises the possibility that Pol III is involved in ageing. Here we show that Pol III limits lifespan downstream of TORC1. We find that a reduction in Pol III extends chronological lifespan in yeast and organismal lifespan in worms and flies. Inhibiting the activity of Pol III in the gut of adult worms or flies is sufficient to extend lifespan; in flies, longevity can be achieved by Pol III inhibition specifically in intestinal stem cells. The longevity phenotype is associated with amelioration of age-related gut pathology and functional decline, dampened protein synthesis and increased tolerance of proteostatic stress. Pol III acts on lifespan downstream of TORC1, and limiting Pol III activity in the adult gut achieves the full longevity benefit of systemic TORC1 inhibition. Hence, Pol III is a pivotal mediator of this key nutrient-signalling network for longevity; the growth-promoting anabolic activity of Pol III mediates the acceleration of ageing by TORC1. The evolutionary conservation of Pol III affirms its potential as a therapeutic target.
. This specialization is evident in the biogenesis of the translation machinery, a task that requires the co-ordinated activity of all three polymerases: Pol I generates the 45S pre-rRNA that is subsequently processed into mature rRNAs, Pol II transcribes various RNAs including mRNAs encoding ribosomal proteins, while Pol III provides the tRNAs and 5S rRNA. This costly process of generating protein synthetic capacity is tightly regulated to match the extrinsic conditions and the intrinsic need for protein synthesis by the key driver of cellular anabolism, TORC1 5, 6 . The central position of TORC1 in the control of fundamental cellular processes is mirrored by the notable effect of its activity on organismal physiology: following its initial discovery in worms 7 , inhibition of TORC1 has been demonstrated to extend lifespan in all tested organisms, from yeast to mice 8, 9 , with beneficial effects on a range of age-related diseases and dysfunctions 3, 10 . TORC1 strongly activates Pol III transcription 5, 6 and this relationship suggests the possibility that inhibition of Pol III promotes longevity.
In Saccharomyces cerevisiae, each of the 17 Pol III subunits is encoded by an essential gene. We generated a yeast strain in which the largest Pol III subunit (C160, encoded by RPC160, also known as RPO31) 4 is fused to the auxin-inducible degron (AID). The fusion protein can be targeted for degradation by the ectopically expressed E3 ubiquitin ligase (OsTir) in the presence of indole-3-acetic acid (IAA) 11 to achieve conditional inhibition of Pol III (Extended Data Fig. 1a ). We confirmed that IAA treatment triggered degradation of the fusion protein (Fig. 1a) , and observed that IAA treatment also improved the survival of the RPC160-AID strain upon prolonged culture (Fig. 1b) . In addition, IAA treatment of the control strain lacking the AID fusion 1 Institute of Healthy Ageing, Department of Genetics, Evolution and Environment, University College London, Gower Street, London WC1E 6BT, UK. 2 School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK. , Feeding E. coli expressing the rpc-1 RNAi construct to N2 C. elegans from the L4 stage reduces the levels of rpc-1 mRNA (c, P < 10 −4 , two-tailed t-test) and extends the lifespan of worms relative to vector alone at 20 °C in the presence of 5′ -fluorodeoxyuridine (FUDR) (d; log-rank test, P = 0.03; empty vector, n = 86; rpc-1 RNAi, n = 94; representative of three trials). e, f, Female flies heterozygous for dC53
EY have reduced dC53 expression (e; two-tailed t-test, P = 10 −4 ; wild type (WT), 95% confidence intervals (c.i.) = 0.89-1.1; dC53 EY/+ , c.i. = 0.64-0.71) and extended lifespan (f; logrank test, P = 6 × 10 −13 ; wild type, n = 152; dC53 EY/+ , n = 144; single trial). Bar charts show mean ± s.e.m.; n, number of biologically independent samples; overlay, individual data points. For more detailed demography and a summary of worm and fly lifespan trials see Extended Data Figs 2c and 4a. Gel source data is shown in Supplementary Fig. 1 .
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reduced its survival relative to both the same strain in the absence of IAA and to the RPC160-AID strain in the presence of IAA (Extended Data Fig. 1b) . Hence, Pol III depletion appears to extend the chronological lifespan in yeast. While IAA had no substantial effect on the survival of a strain carrying the AID domain fused to the largest subunit of Pol II (RPB220, also known as RP021), this strain appeared to survive better than the control strain did in the presence of IAA (Extended Data  Fig. 1a, b) , indicating that inhibition of Pol II may also extend chronological lifespan. Chronological lifespan of yeast is a measure of survival in a nutritionally limited, quiescent population, whereas replicative lifespan measures the number of daughters produced by a single mother cell in its lifetime. We found no evidence that inhibition of Pol III causes an increase in the replicative lifespan in yeast (Extended Data Fig. 1c) .
The observed increase in chronological lifespan may simply indicate increased stress resistance and hence be of limited relevance to organismal ageing. To examine the role of Pol III in organismal ageing directly, we turned to animal models. We initiated RNA-mediated interference (RNAi) against rpc-1, the Caenorhabditis elegans orthologue of RPC160, in worms from the L4 stage, causing a partial knockdown of rpc-1 mRNA (Fig. 1c) . This consistently extended the lifespan of worms at both 20 °C and 25 °C ( Fig. 1d ; Extended Data Fig. 2a-c) . To reduce Pol III activity in Drosophila melanogaster, we back-crossed a P-element insertion that deletes the transcriptional start site of the gene encoding the Pol III-specific subunit C53 (CG5147 EY22749 , henceforth called dC53 EY , Extended Data Fig. 3 ) into a healthy, outbred population of flies. Homozygous dC53 EY/EY mutants were not viable, but heterozygous females had reduced dC53 mRNA levels and lived longer than controls ( Fig. 1e, f; Extended Data Fig. 4a ). Taken together, our data strongly indicate that Pol III limits lifespan in multiple model organisms and conversely, that partial inhibition of its activity is an intervention that increases longevity in multiple species.
The longevity of an animal can be governed from a single organ. In the worm, this role is often played by the gut 12, 13 . To restrict the rpc-1 knockdown to the gut, we used worms deficient in rde-1, in which the RNAi machinery deficiency is restored in the gut by gut-specific rde-1 rescue 14 . rpc-1 RNAi extended the lifespan of this strain, both at 20 °C and 25 °C (Fig. 2a, Extended Data Fig. 2d ). Similarly, in the adult fly, driving an RNAi construct targeting the RPC160 orthologue (CG17209, henceforth called dC160, Extended Data Fig. 3 ) with the mid-gut-specific, RU486-inducible driver TIGS (ref. 15 ) extended the lifespan of females (Fig. 2b) , while the presence of the inducer (RU486) did not affect survival of the control strains (Extended Data Fig. 4b, c) . The longevity phenotype could also be recapitulated with RNAi against dC53, another Pol III subunit (Extended Data Fig. 4d ), indicating that the phenotype was not subunit-specific or due to off-target effects. As well as the gut, longevity can also be associated with the fat body and neurons in flies 13 . However, the longevity phenotype caused by dC160 RNAi appears to be specific to the gut, since no significant lifespan extension was observed upon induction of dC160 RNAi in the fat body of the adult fly, and only a modest, albeit significant, extension resulted from neuronal induction of dC160 RNAi (Extended Data Fig. 4e, f) .
The worm gut is composed of only post-mitotic cells. In flies, as in mammals, the adult gut epithelium contains mitotically active intestinal stem cells 16 (ISCs). ISC homeostasis is important for longevity 17 , and the mid-gut-specific driver TIGS appears to be active in at least some ISCs (Extended Data Fig. 5 ), prompting us to restrict dC160 RNAi induction to this cell type. ISC-specific dC160 RNAi, achieved with the GS5961 driver, was sufficient to promote longevity (Fig. 2c , see Extended Data Fig. 4b, g for controls) . In summary, Pol III activity in the gut limits survival in worms and flies, and in the fly, Pol III can drive ageing specifically from the gut stem-cell compartment.
We assessed the consequences of Pol III inhibition in the fly gut. Pol III acts to generate precursor tRNAs (pre-tRNAs) that are processed rapidly to mature tRNAs. Owing to their short half-lives, pre-tRNAs are useful as readouts of in vivo Pol III activity. Profiling the levels of specific pre-tRNAs, pre-tRNA His , pre-tRNA Ala and pre-tRNA Leu , relative to the levels of U3 (a small nucleolar RNA transcribed by 
Pol II 18 ) revealed a moderate but significant reduction in Pol III activity upon gut-specific induction of dC160 RNAi (Fig. 2d) . The three polymerases can be directly coordinated to generate the translation machinery 19 . Indeed, Pol III inhibition had knock-on effects on Pol I-but not Pol II-generated transcripts, revealing partial cross-talk (Extended Data Fig. 6a, b) . dC160 RNAi also reduced protein synthesis in the gut (Fig. 2e, Extended Data Fig. 6c ), consistent with reduced Pol III activity. These effects (reduction in pre-tRNAs or protein synthesis) were not observed after feeding RU486 to the driver-only control (Extended Data Fig. 6d-f ). The reduction in protein synthesis was not pathological: total protein content of the gut was unaltered; fecundity, a sensitive readout of a female's nutritional status, was unaffected; and the flies' weight, triacylglycerol and protein levels remained unchanged (Extended Data Fig. 6g-i) . Reduced protein synthesis can liberate protein-folding machinery from protein production and increase homeostatic capacity 20 . Indeed, induction of dC160 RNAi in the gut increased the resistance of adult flies to proteostatic challenge with tunicamycin ( Fig. 2f , and Extended Data Fig. 6j for TIGS-only control). Hence, Pol III can fine-tune the rate of protein synthesis in the adult fly gut without obvious detrimental outcomes, while increasing resistance to proteotoxic stress.
Having demonstrated the relevance of Pol III for ageing, we investigated whether it acts on lifespan downstream of TORC1 in Drosophila. Numerous observations in several organisms support the model in which TORC1 localizes on Pol III-transcribed loci and promotes phosphorylation of the components of the Pol III transcriptional machinery to activate transcription, in part by inhibition of the Pol III repressor, Maf1 5 . Using chromatin immunoprecipitation (ChIP) with two independently generated antibodies against Drosophila TOR (target of rapamycin) 21, 22 , we observed TOR enrichment on Pol IIItarget genes in the adult fly, relative to Pol II targets ( Fig. 3a ; Extended Data Fig. 7a-e ). Inhibition of TORC1 by feeding rapamycin to flies reduced the levels of pre-tRNAs in whole flies (Fig. 3b) . Rapamycin also reduced pre-tRNA levels specifically in the gut relative to U3 (Fig. 3c) . Since rapamycin results in re-scaling of the gut, evidenced by the reduction in the total RNA content of the organ (Extended Data Fig. 7f ), we also confirmed that the drug reduced pre-tRNA levels relative to total RNA (Extended Data Fig. 7g ). Interestingly, rapamycin did not cause a decrease in 45S pre-rRNA in the gut (Extended Data Fig. 7h, i) , suggesting a lack of sustained Pol I inhibition. Additionally, gut-specific overexpression of Maf1 reduced the levels of pre-tRNAs and extended lifespan (Fig. 3d, Extended Data Fig. 7j ), confirming that Maf1 acts on Pol III in the adult gut. These data are consistent with TORC1 driving systemic and gut-specific Pol III activity in the adult fruitfly.
To examine whether the lifespan effects of Pol III are downstream of TORC1, we combined adult-onset Pol III inhibition with rapamycin treatment. Rapamycin feeding or gut-specific dC160 RNAi resulted in the same magnitude of lifespan extension (Fig. 3e) . The two treatments were not additive (Extended Data Fig. 8a ), consistent with their acting on the same longevity pathway. The same effect was observed with RNAi against dC53 in the gut (Extended Data Fig. 8b) , as well as when dC160 RNAi was restricted to the ISCs (Fig. 3f) . Importantly, rapamycin feeding also inhibited phosphorylation of the TORC1 substrate, S6 kinase 3 (S6K), in both the gut and the whole fly, and decreased fecundity, while gut-specific C160 RNAi did not have these effects (Fig. 3g , h, Extended Data Fig. 8c-f ). This confirms that Pol III inhibition does not impact TORC1 activity locally or systemically, and therefore, Pol III acts downstream of TORC1 in ageing (Fig. 3i) .
TORC1 inhibition is known to ameliorate age-related pathology and functional decline of the gut 23 . We examined whether inhibition of Pol III was sufficient to block the dysplasia resulting from RNAi flies, and rapamycin feeding both extend lifespan, and their effects are not additive (Cox proportional hazards (CPH); rapamycin, P = 2 × 10 −14 ; RU486, P < 2 × 10 −16 ; interaction, P = 7 × 10 −9 ; control, n = 135; RU486, n = 144; rapamycin, n = 141; RU486 + rapamycin, n = 146; single trial). f, Induction of dC160 RNAi in ISCs by feeding RU486 to female GS5961 > dC160
RNAi flies, and rapamycin feeding both extend lifespan and their effects are not additive (CPH; rapamycin, P = 8 × 10 −14 ; RU486, P = 2 × 10 −5 ; interaction, P = 3 × 10 −7 ; control, n = 113; RU486, n = 130; rapamycin, n = 145; RU486 + rapamycin, n = 144; single trial). g, h, Treatment with rapamycin, but not dC160
RNAi induction in the gut by feeding RU468 to female TIGS > dC160
RNAi flies leads to a reduction in S6K phosphorylation in the gut and the whole fly (g; representative of four biologically independent repeats; see Extended Data Fig Fig. 9b ). We also found that rpc-1 RNAi reduced the severity of age-related loss of gut-barrier function in worms (Extended Data Fig. 9c ). In Drosophila, gut health 25 and TORC1 inhibition 26 are specifically linked to female survival. Indeed, induction of dC160 RNAi in the gut had a sexually dimorphic effect on lifespan, as the effect on males, although significant, was lower in magnitude relative to the effect on females (Extended Data Fig. 9d) . Overall, our data show that gut-or ISC-specific inhibition of Pol III, which extends lifespan, is sufficient to ameliorate age-related impairments in gut health, which may be causative of or correlate with this longevity.
Our study demonstrates that the adult-onset decrease in the growth-promoting anabolic function mediated by Pol III in the gut, and specifically in the intestinal stem-cell compartment, is sufficient to recapitulate the longevity benefits of rapamycin treatment. Pol III activity is essential for growth 6 ; its detrimental effects on ageing suggest an antagonistic pleiotropy 27 in which wild-type levels of Pol III activity are optimised for growth and reproductive fitness in early life but prove detrimental for later health. We reveal a fundamental role for Pol III in adult physiology, implicating wild-type Pol III activity in age-related stem-cell dysfunction, declining gut health and organismal survival downstream of nutrient signalling pathways. The longevity resulting from partial Pol III inhibition in adulthood is likely to result from the reduced provision of protein synthetic machinery; however, differential regulation of tRNA genes or Pol III-mediated changes to chromatin organization may also be involved, as has been suggested in other contexts 2 . The strong structural and functional conservation of Pol III in eukaryotes suggests that studies of its influence on mammalian ageing are warranted and could lead to important therapies.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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No statistical methods were used to predetermine sample size. Where animals of the same genotype were assigned to different treatments, the assignment was done randomly and in a way to avoid batching effects; no other randomization procedures were used. The investigators were not blinded to allocation during experiments and outcome assessment. Yeast stocks, chronological lifespans and microfluidics assessment. A pMK43-based cassette was integrated into w303 MATa leu2-3,112 trp1-1 can1-100 ura3-1 pADH-OsTir-9Myc::ADE2::ade2-1 his3-11,15 to produce RPC160 or RPB220 C-terminal AID fusions as previously described 11 . Strains were confirmed by PCR and absence of growth in presence of 2.5 mM IAA. The following primers were used for strain construction: C160 f or wa rd, T GT CT AT TT GA AA GT CT CT CA AA TG AG GC AG CT TT AA AA GC GA ACCGTACGCTGCAGGTCGAC; C160 r ev er se, A GA AA AA TA AT AC AA AT GC TA TA AA AA AG TT TA AA AA CG AC TA C TATCGATGAATTCGAGCTCG; B220 forward, C C A AA G C AA G A CG A A CA A A AG C A TA A T GA A A AT G A AA A T TC CA GACGTACGCTGCAGGTCGAC; B220 reverse, A TA TATAATGTAATAACGTCAAATACGTAAGGATGATAT ACTATAATCGATGAATTCGAGCTCG. The following primers were used for verification: C160 forward, TTGGGTCAAACGATGTCG; B220 forward, CGCCTTCATACTCTCCAAC; C160/B220 reverse, TGCCCATCATGGTACCTG.
For chronological lifespan experiments, the strains were grown to exponential phase (OD 600 nm ≈ 0.4) in Synthetic Complete medium (2% glucose, 0.5% ammonium sulfate, 0.17% yeast nitrogen base, 0.001% each of adenine, uracil, tryptophan, histidine, arginine and methionine, 0.0025% phenylalanine, 0.003% each of tyrosine and lysine, 0.004% isoleucine, 0.005% each of glutamate and aspartate, 0.0075% valine, 0.01% threonine, 0.02% each of serine and leucine (w/v)), the culture was split and treated with IAA in acetone or acetone alone (0.1%, day 0) and incubated with aeration and shaking at 30 °C. Samples were collected for protein extraction after 30 min. The cultures essentially reached stationary phase after 24 h. Viability was measured on the indicated days by plating 5 μ l of tenfold serial dilutions, starting from an initial concentration corresponding to OD 600 nm = 0.5, on YEPD plates and growing them for 2 days at 30 °C.
For replicative lifespan experiments, cells from single colonies were inoculated in 10 ml of minimal medium 28 containing 1% glucose, 0.02% leucine and 0.001% each of tryptophan, arginine, histidine and uracil (w/v) (pH 5, maintained with potassium phthalate-KOH buffer). The cultures were cultivated overnight in 100 ml flasks at 30 °C, shaking at 300 r.p.m. The following morning, cultures were diluted to an OD 600 nm of 0.005-0.01 while still in the exponential growth phase, and cultivated for several hours to an OD 600 nm of 0.045-0.09. They were then loaded into the microfluidics device as previously described 29, 30 , the growth medium having been aerated in advance by shaking for at least 2 h. Cells in the device were constantly supplied with fresh medium containing the synthetic auxin hormone 1-naphthaleneacetic acid (NAA) at concentrations of 0.0005, 0.001, 0.005 or 0.01 mM; the control medium did not contain NAA. These concentrations of the hormone span the dynamic range of the auxin-based degron system with which the degree of protein depletion can be efficiently modulated in this setup 31 . The temperature was maintained at 30 °C throughout the experiment.
Bright-field images were recorded at 5-min intervals for up to 5 days, using a Nikon Ti-E inverted microscope equipped with a 40× Nikon Super Fluor Apochromat objective and a halogen lamp with an additional UV-blocking filter. Time points of budding events, the eventual cell losses due to wash away or cell death were recorded by visual inspection of the time-lapse images with the help of ImageJ and a custom macro. For assessment of cell division times, the first six cell cycles of each cell were used. Worm husbandry, lifespans and gut integrity assay. Before experiments, animals were maintained at 20 °C and grown for at least three generations with ample OP50 E. coli food to assure full viability. Hermaphrodites were used for experiments. The rpc-1 RNAi clone (gene code C42D4.8) was obtained from the Ahringer C. elegans RNAi library. Lifespan assays were performed on HT115 E. coli expressing either the rpc-1 RNAi plasmid or the pL4440 empty vector control as food source. Experiments were carried out at both 20 °C and 25 °C. Worms were scored as dead or alive at intervals, and worms that crawled off the plate, died from explosion or displayed bagging phenotypes were censored. rpc-1 RNAi treatment from the L4 stage increased the incidence of a vulval-explosion phenotype (noted in Extended Data Fig. 2c ). However, we found that this phenotype was greatly reduced at 25 °C (Extended Data Fig. 2c ). The VP303 strain 14 was used for gut-targeted RNAi experiments. The Smurf assay for gut integrity was carried out essentially as previously described 32 . Worms were aged from the L4 stage at 25 °C and soaked in blue dye for 3 h at the desired age. The dye was removed by allowing the worms to move around on a bacterial lawn for 30 min before microscopy analysis. Individual worms were scored on their degree of 'Smurfness' , with 0 signifying no blue beyond the gut barrier and 4 signifying complete dispersion of blue dye. 37 containing 10% brewer's yeast, 5% sucrose, and 1.5% agar (all w/v, with propionic acid and Nipagin as preservatives). RU486 (Sigma) and rapamycin (LC Laboratories, both dissolved in ethanol) were added to a final concentration of 200 μ M as required. Tunicamycin (10 mg l −1 , Cell Signaling, DMSO stock) was added to sugar and agar food. In control treatments, equivalent volumes of the vehicle alone were added.
Flies were reared at standardized larval density and adults were collected over 12 h, allowed to mate for 48 h and sorted into experimental vials at a density of 15 flies per vial (10 flies per vial for RNA extractions). For lifespan experiments, flies were transferred to fresh vials and their survival was scored three times a week. Flies were transferred onto food containing tunicamycin on day 9 and survival was scored once or twice daily. For Smurf assays, flies at the indicated age were placed on SYA food containing 2.5% (w/v) blue dye (FD & C blue dye no. 1, Fastcolors) for 48 h. Flies were scored as full Smurfs if completely blue and partial Smurfs if the dye had leaked out of the gut but had not reached the head. Eggs laid over ~ 24 h were counted on day 10. Other phenotypic tests were performed essentially as previously described 38 . RNA extraction, qPCR and RNA sequencing. Synchronised populations of worms were grown at 20 °C on control or rpc-1 RNAi-containing substrate at the L4 stage, and collected after 4 days. Ten whole adult flies, or ten dissected mid-guts, were harvested on day 7-9. Total RNA was isolated using TRIZOL (Invitrogen). RNA isolation was quantitative-the amount obtained was proportional to the starting amount. RNA was converted to cDNA using random hexamers and Superscript II (Invitrogen). Quantitative PCR was performed using Power SYBR Green PCR Master Mix (ABI), using the relative standard curve method. For worms, rpc-1 transcript levels were normalized to the geometric mean of three stably expressed reference genes: cdc-42, pmp-3 and Y45F10D.4 as previously described 39 . For fly experiments, the following primers specific for pre-tRNAs were designed based on previous biochemical characterization 40 or predicted intronic sequences 41 : dC53 (CG5147) forward, GGGTGACCCAGAGTCCCT; dC53 (CG5147) reverse, GGCGAGCTCAGCGAAGAG; pre-rRNA ITS forward, TTAGTGTGGGGCTTGGCAACCT; pre-rRNA ITS reverse, CGCCGTTGTT GTAAGTACTCGCC; pre-rRNA ETS forward, GTTGCCGACCTC GCATTGTTCG; pre-rRNA ETS reverse, CGGAGCCAAGTCCCGTGTTCAA; pre-tRNA His For RNA sequencing (RNA-seq) analysis, RNA was further cleaned up with Qiagen RNeasy (Qiagen), ribo-depleted (Ribo-Zero Gold; Illumina) and sequenced on the Illumina platform at Glasgow Polyomics (75 base pairs, pair-end reads). Transcript abundance was estimated with Salmon 42 (https://combine-lab.github.io/ salmon/) in quasi-mapping mode onto all Drosophila cDNA sequences (BDGP6), imported with tximport (https://bioconductor.org/packages/release/bioc/html/ tximport.html) into R (https://www.r-project.org/) and differential expression was determined with DESeq2 (https://bioconductor.org/packages/release/bioc/html/ DESeq2.html) using dissection batch as covariate at 10% false discovery rate 43 . Western blots, immunoprecipitation, S2 dsRNA treatment, translation assays and ChIP. Proteins were extracted with trichloroacetic acid from yeast (10 ml culture), S2 cells (0.1-2 ml culture; S2 cells were obtained from L. Partridge, confirmed by growth in appropriate medium and morphology), ten flies or ten dissected mid-guts, washed and resuspended in SDS-PAGE loading buffer, separated by SDS-PAGE and transferred to nitrocellulose. Western blots were performed with antibodies against puromycin (12D10, Millipore), actin (ab1801 or ab8224, Abcam), Myc (Sigma), Flag (Sigma), phospho-T398-S6K (9209, Cell Signaling), S6K 44 and TOR 21 . Immunoprecipitations were performed on ~ 2 mg of total protein extracted from 2-5 ml of S2 cell cultures (transfected with pAFW-dTOR, treated with dsRNA or untreated) into 50 mM HEPES-KOH pH 8, 100 mM KCl, 5 mM EDTA, 10% glycerol, 0.5% NP-40 and protease inhibitors with 0.5 μ l of anti-dTOR serum 21 , washed five times with the same buffer and eluted into SDS-PAGE sample buffer. The dsRNA against dTOR corresponds to a fragment containing bases 3694-4208 of the dTOR open reading frame (this is DRSC02811 from DRSC/TRiP) and was generated with the Megascript RNAi Kit (Thermo Fisher Scientific).
Relative translation rates were determined with the SUnSET assay 45 . Ten midguts of seven-day-old flies per sample were dissected in ice-cold PBS and kept in 200 μ l of ice-cold Schneider's medium followed by incubation in 1 ml of Schneider's medium with 10 μ g ml −1 puromycin for 30 min at 25 °C. The reaction was stopped by adding 333 μ l of 50% trichloroacetic acid. The level of puromycin incorporation was determined by western blot.
ChIP was performed as previously described 46 on chromatin prepared from 7-day-old, wild-type females using anti-TOR antibodies raised against either a recombinant TOR protein fragment 21 , or a peptide 22 . The mock control included no antibody. Enrichment after immunoprecipitation was measured relative to input by qPCR. Primers for 5′ and 3′ ends of aop and the P2 InR promoter have been described previously 46, 47 . Other primers used were: 5S rRNA forward, GCCAACGACCATACCACGCTG; 5S rRNA reverse, AGTACT AACCGCGCCCGACG; tRNA Met forward, CGCAGTTGGCAGCGCGTAAG; tRNA Met reverse, CCCCGGGTGAGGCTCGAACT. pH3, Prospero and anti-HRP staining. Guts from animals at the indicated ages were dissected in ice-cold PBS and immediately fixed in 4% formaldehyde for 30 min. The staining was performed essentially as described 38 , with antibodies against phospho-H3 (9701, Cell Signaling), Prospero (Developmental Studies Hybridoma Bank) or horseradish peroxidase 48 (HRP). Guts were mounted in mounting medium with DAPI (Vectastain). The number of pH3-positive cells in each mid-gut was counted under a fluorescence microscope. Representative images were acquired with the Zeiss LSM700 confocal microscope. Statistical analysis. Fly and worm data Survival assays were analysed with the log-rank test in Microsoft Excel, JMP (SAS) or with CPH in R using the survival package (https://cran.r-project.org/web/packages/survival/index.html). All other tests were performed in JMP. Data obtained from dissections, ChIP or western blots were scaled to the dissection, chromatin or replicate batch, except for pH3 counts, to account for batching effects. MANOVA was used to test for the overall effect of RU486 or rapamycin feeding. For ChIP analysis, 'gene' was used as covariate in a linear model with an a priori contrast comparing Pol III-to Pol II-transcribed genes. All regression models had a fully factorial design.
Yeast microfluidics platform The data, including the number of buds produced by each cell and its final event (death or washout), were used for Kaplan-Meier estimation of survival curves with the Lifelines module (Davidson-Pilon, C., Lifelines, (2016), Github repository, https://github.com/CamDavidsonPilon/lifelines) in Python. Plotting and statistical analysis were done in Python. Code availability. A custom designed code was used to analyse the yeast replicative lifespan data and will be made available upon reasonable request. Data availability. The data that support the findings of this study are available within the paper and its Supplementary Information files, including source data for figures, or are available from the corresponding author upon reasonable request.
RNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-5252. Fig. 1b . The bottom panels show a single experiment; the improved survival of RPB220-AID was also observed at a higher IAA concentration in a second experiment. c, Duration of cell cycle (bottom panels), but not replicative lifespan (top panels), is altered by 1-naphthaleneacetic acid (NAA; analogue of IAA). Both were assessed in the pADH-OsTir RPC160-AID strain on a microfluidics dissection platform. The concentrations of NAA span the dynamic range in which the degree of protein depletion can be efficiently modulated in this setup 31 . The same control data are shown in each panel for comparison. One experiment was performed for each NAA concentration. For replicative lifespan experiments, 95% c.i. is indicated by shading (or in brackets for median lifespan), together with log-rank P value. A one-sided Mann-Whitney U test was used to test for significant differences in cell-cycle duration. No adjustments were made for multiple comparisons. Dashed lines on bottom panels represent medians. Extended Data Figure 2 | Inhibition of Pol III extends worm lifespan. a, Lifespan is extended by feeding N2 worms with rpc-1 RNAi at 20 °C in the absence of FUDR (log-rank test, P < 10 −3 ; control and rpc-1 RNAitreated, n = 100). b, Lifespan is also extended at 25 °C in the presence of FUDR (log-rank test, P = 9 × 10 −3 ; control, n = 60; rpc-1 RNAi, n = 77). c, Summary of each worm lifespan experiment, including the representative trials presented in the figures. P values for log-rank tests are shown. The total number of animals in the trial = dead + censored. In general, fewer worms were censored in control conditions compared to rpc-1 RNAi conditions (mean number of censored N2 worms at 25 °C = 25% (control) and 38% (rpc-1 RNAi); mean number of censored N2 worms at 20 °C = 53% (control) and 73% (rpc-1 RNAi); mean number of censored VP303 at 25 °C = 3% (control) and 4% (rpc-1 RNAi), and mean number of censored VP303 at 20 °C = 37% (control) and 54% (rpc-1 RNAi)), which is likely to be due to an increased number of gut explosions in the rpc-1 RNAi treated worms. 84.9% of censoring events in controls and 85.6% of those in rpc-1 RNAi-treated animals occurred before the 25th percentile of the survival curve. Overall, increasing the temperature to 25 °C reduced censoring without altering our findings. d, Lifespan is extended when the RNAi against rpc-1 is restricted to the gut by using the VP303 strain at 25 °C in the presence of FUDR (log-rank test, P = 9 × 10 −3 ; control, n = 84; rpc-1 RNAi n = 103). In a, b and d, a representative of two trials is shown. Fig. 8a ). Experiments were performed on females unless otherwise noted. The total number of animals in the trial = dead + censored. log-rank test P value is reported. b, c, Feeding with RU486 does not have an effect on the lifespans of: UAS-dC160 RNAi -only controls (b; log-rank test, P = 0.28; control, n = 142; RU486, n = 146); or TIGSonly controls (c, log-rank test, P = 0.41, control, n = 141 RU486, n = 145). d, Inducing dC53 RNAi in the gut by feeding RU486 to female TIGS > dC53 RNAi flies extends their lifespan (log-rank test, P = 3 × 10 −6 ; control, n = 143; RU486-treated, n = 139). e, Inducing dC160
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RNAi predominantly in the fat body by feeding RU486 to S 1 106 > dC160
RNAi flies has no effect on their lifespan (log-rank test, P = 0.21; negative control, n = 158; RU486, n = 155). f, Inducing dC160
RNAi in neurons by feeding RU486 to elavGS > dC160
RNAi females by RU486 has a modest effect on their lifespan (P = 0.03, log-rank test; negative control, n = 148; RU486, n = 155). g, RU486 feeding does not have an effect on the lifespan of the GS5961-only controls (log-rank test, P = 0.88; negative controls, n = 89; RU486, n = 91). Experiments in b-g were performed as single trials. 21 and used for ChIP (Fig. 3a) recognizes a single band of the expected size on western blots of S2 cell extracts. b, The same antibody can immunoprecipitate (IP) TOR from S2 cells expressing endogenous and Flag-tagged TOR. c, It can also immunoprecipitate endogenous TOR, and the intensity of this band is reduced upon RNAi treatment against TOR in S2 cells with dsRNA. Single experiments were performed for a-c; the ability of the TOR RNAi to reduce the intensity of the band was confirmed in an independent experiment. d, ChIP using a different antibody against Drosophila TOR (raised against a peptide 22 ) shows that relative enrichment of Pol III-transcribed genes is higher than that of Pol II-transcribed genes (linear model with an a priori contrast, P = 2 × 10 −4 ; n = 3 biologically independent samples; left to right, c.i. = 1.6-2.6, 0.81-2.3, 1.1-2.7, 0.77-2.8, − 0.24-2.5, − 0.065-2.0 and 0.13-1.7). e, No enrichment of Pol III-transcribed genes over Pol IItranscribed genes is observed after mock ChIP with no antibody (linear model with an a priori contrast, P = 0.09, n = 3 biologically independent samples). f, Rapamycin feeding results in a decrease in total RNA content of the adult gut (two-sided t-test, P < 10 −4 ). g, Rapamycin feeding results in reduction of pre-tRNAs relative to total RNA in the fly gut (MANOVA, P = 10 −4 ). h, i, Rapamycin feeding does not result in a reduction of prerRNA in the fly gut relative to U3 (h; MANOVA, P < 10 −4 ) or total RNA (i; MANOVA, P = 0.57). j, HA-Maf1 induction specifically in the gut by feeding RU486 to female TIGS > HA-Maf1 flies extends their lifespan (log-rank test, P = 0.006; control, n = 153; RU486, n = 146; single trial). Bar charts show mean ± s.e.m.; n, number of biologically independent samples; overlay, individual data points. Gel source data is shown in Supplementary Fig. 1 . Age-related loss of gut barrier function in worms has been described previously 32 . d, Induction of dC160 RNAi in the gut by feeding RU486 to adult male TIGS > dC160
Letter reSeArCH
RNAi flies results in a small but significant extension of lifespan (log-rank test, P = 0.03; no-RU486, n = 141; RU486, n = 139; single trial). Bar charts show mean ± s.e.m.; n, number of animals; overlay, individual data points.
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Experimental design 1. Sample size
Describe how sample size was determined. Sample sizes were based on previous experiments of the same type.
Data exclusions
Describe any data exclusions. Some (very few) data points were excluded due to technical failure/issues.
Replication
Describe whether the experimental findings were reliably reproduced.
There were no attempts at replication that failed.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
The samples were allocated to groups randomly, in a way so as to protect against or reduce any batching effects.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The investigators were not blinded to group allocations.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
